Abstract
There are specific frequencies, which are absent in healthy cells, that are present within breast, liver, prostate, and pancreatic cancer cells. These four frequencies 1,873.477 Hz, 2,221.323 Hz, 6,350.333 Hz, and 10,456.383 Hz are utilized in cancer treatment. Recent advancements in cancer treatment have granted FDA approval for low-level RF therapy to modulate these frequencies, for treatment of advanced Carcinoma. This medical treatment utilizes a 27.12 MHz carrier frequency, modulated by unique cancer-specific frequencies, to selectively target cancer cells while avoiding healthy tissues. This research establishes how the membrane potential in cancerous cells is responsible for the origin of these unique tumor- resonance frequencies. By modeling cell membrane behavior in these cancers, additional frequencies are identified in order to enhance therapeutic efficacy. In clinical trials involving terminal patients with metastatic breast cancer that have had infiltration of the liver and other parts of the body, the newly identified frequency for breast cancer, when used in low level RF therapy treatment, has shown promising signs of extended survival time. Positive symptoms and improvements have been noted in patient records and doctors’ observations, thus providing validity for potential clinical benefits. This research emphasizes the importance of further exploring the electrical properties of cancer cells and their therapeutic effects.